Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Naltrexone 100 Mg Active Marijuana (3.27% THC)
Total 0 results
Nothing found
Sponsors and Collaborators
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Hospital Durand, Argentina
ASST Cremona, Cremona
Alma Lasers Inc.
iCAD
Apollo Neuroscience, Inc.
Nacuity Pharmaceuticals, Inc.
RMIT University, Melbourne, Australia
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
Kupfer, David J., M.D.
GFI
Hospital ASEPEYO Sant Cugat
Agency for Science, Technology and Research
Everett Meyer
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Mª Victoria Maestre Sanchez
Neurophth Therapeutics Inc
Aptis Medical
Korean Society of Spine Surgery
Eurofins Genoma
View Full List
Medical Conditions
Artificial Pancreas
Accuracy and Precision of Noninvasive Measurement
Dislocation, Shoulder
Renal Function Disorder
Anaplastic Large-cell Lymphoma
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use
Decay
LOW OVARIAN RESPONSE
Post Covid-19 Condition
Social Anxiety
Surgical Patient
Sporadic
Extraarticular Fracture
Anatomic Stage 2A Breast Cancer AJCC v8
Hospital Acquired Pressure Ulcer
Neck Mass
Age-related Hearing Loss
STEMI - ST-segment Elevation Myocardial Infarction
Optimys Femoral Stem
PD-1 Refractory Advanced Melanoma
View Full List
Drug Interventions
THC
PD-1/PD-L1 inhibitor
Intravenous deferiprone
Anticholinergic
Fospropofol disodium, propofol
RDX227675
Desvenlafaxine
OnabotulinumtoxinA
Standard of care (SOC) for COVID-19
Oxycodone/acetaminophen 5/325 mg
Letrozole
Capecitabine/cisplatin
TPN-101
Olopatadine
Midazolam
Intravenous Formulation of PD-0332991
Camptosar
GLPG1837 multiple ascending doses
Capecitabine and IMRT (if randomized to this arm)
MLN2480
View Full List
CROs by country
Contract Research Organizations in Bosnia & Herzegovina
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Gabon
Contract Research Organizations in Guatemala
Contract Research Organizations in Indonesia
Contract Research Organizations in Iran
Contract Research Organizations in Italy
Contract Research Organizations in Myanmar
Contract Research Organizations in New Zealand
Contract Research Organizations in Portugal
Contract Research Organizations in Spain
Contract Research Organizations in Ukraine
Contract Research Organizations in Vietnam
CRO list by country
CROs in Cambodia
Lucerent
SGS
All CROs in Cambodia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe